AMRX Butterfly Strategy
AMRX (Amneal Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE. The Generics division is responsible for creating, producing, and bringing to market a diverse portfolio of complex pharmaceutical formulations. This includes oral solid doses, injectable solutions, ophthalmic preparations, liquid medications, topical applications, softgels, inhalants, and transdermal patches, all catering to a broad spectrum of medical needs. Within the Specialty division, the company concentrates on the advancement, marketing, sales, and distribution of proprietary branded pharmaceuticals.
AMRX (Amneal Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $5.50B, a trailing P/E of 46.32, a beta of 1.32 versus the broader market, a 52-week range of 7.665-17.86, average daily share volume of 1.7M, a public-listing history dating back to 2018, approximately 8K full-time employees. These structural characteristics shape how AMRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.32 indicates AMRX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 46.32 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a butterfly on AMRX?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current AMRX snapshot
As of June 30, 2026, spot at $17.27, ATM IV 40.30%, IV rank 6.79%, expected move 11.55%. The butterfly on AMRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this butterfly structure on AMRX specifically: AMRX IV at 40.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a AMRX butterfly, with a market-implied 1-standard-deviation move of approximately 11.55% (roughly $2.00 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMRX should anchor to the underlying notional of $17.27 per share and to the trader's directional view on AMRX stock.
AMRX butterfly setup
The AMRX butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMRX near $17.27, the first option leg uses a $16.41 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMRX chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $16.41 | N/A |
| Sell 2 | Call | $17.27 | N/A |
| Buy 1 | Call | $18.13 | N/A |
AMRX butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
AMRX butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on AMRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on AMRX
Butterflies on AMRX are pinning bets - traders use them when they expect AMRX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
AMRX thesis for this butterfly
The market-implied 1-standard-deviation range for AMRX extends from approximately $15.27 on the downside to $19.27 on the upside. A AMRX long call butterfly is a pinning play: it pays maximum at the middle strike if AMRX settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current AMRX IV rank near 6.79% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMRX at 40.30%. As a Healthcare name, AMRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMRX-specific events.
AMRX butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMRX alongside the broader basket even when AMRX-specific fundamentals are unchanged. Always rebuild the position from current AMRX chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on AMRX?
- A butterfly on AMRX is the butterfly strategy applied to AMRX (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With AMRX stock trading near $17.27, the strikes shown on this page are snapped to the nearest listed AMRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AMRX butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the AMRX butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 40.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AMRX butterfly?
- The breakeven for the AMRX butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMRX market-implied 1-standard-deviation expected move is approximately 11.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on AMRX?
- Butterflies on AMRX are pinning bets - traders use them when they expect AMRX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current AMRX implied volatility affect this butterfly?
- AMRX ATM IV is at 40.30% with IV rank near 6.79%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.